Hereditary Prostate Cancer Panel

New York
Approved


Genes

ATM, BRCA1, BRCA2, BRIP1, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6, NBN, PALB2, PMS2, RAD51C, RAD51D, TP53

Conditions

  • Prostate Cancer

Clinical Utility

  • Prostate cancer diagnosed at an early age
  • Metastatic/aggressive prostate cancer
  • Multiple cancers in one person (such as prostate and pancreatic cancer)
  • Multiple relatives diagnosed with prostate cancer (especially aggressive; Gleason score ≥ 7) and/or related cancers (including breast, ovarian, pancreatic, colon, endometrial etc.) on the same side of the family and spanning multiple generations

Lab Method

  • Deletion/Duplication Analysis
  • Next-Gen Sequencing

Test Code

J665

CPT Codes*

81408x1; 81162x1; 81479x1; 81403x1; 81292x1; 81294x1; 81295x1; 81297x1; 81298x1; 81300x1; 81307x1; 81317x1; 81319x1; 81351x1

ABN Required

No

Turnaround Time**

2 weeks

Preferred Specimen

2-5 mL Blood - Lavender Top Tube

Alternative Specimen

Buccal Swabs | Fibroblasts (separate charge for cell culture may apply)

*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

**Turnaround times are estimates and begin once the sample(s) begin processing at the GeneDx lab and could be extended in situations outside GeneDx’s control.